Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

AIDS Drugs Market Research Reports

Titlepublishedprice

Telzir -Drug Insights, 2016

By Delve Insight
"...... s the Telzir sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Telzir , patents information and exclusivity data, route of synthesis, competitive landscap......"
01-Nov-2016$1000

Truvada -Drug Insights, 2016

By Delve Insight
"...... des the Truvada sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Truvada, patents information and exclusivity data, route of synthesis, competitive lands......"
01-Nov-2016$1000

HIV Attachment Inhibitor -Pipeline Insights, 2016

By Delve Insight
"...... y, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA &......"
01-Nov-2016$1250

HIV Protease Inhibitors -Pipeline Insights, 2016

By Delve Insight
"...... Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & E......"
01-Nov-2016$1250

HIV-1 Protease (HIV-1 PR) Inhibitors -Pipeline Insights, 2016

By Delve Insight
"...... pment including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fund......"
01-Nov-2016$1250

Atripla -Drug Insights, 2016

By Delve Insight
"...... des the Atripla sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Atripla, patents information and exclusivity data, route of synthesis, competitive lands......"
01-Nov-2016$1000

HIV-2 Protease (HIV-2 PR) Inhibitors -Pipeline Insights, 2016

By Delve Insight
"...... pment including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fund......"
01-Nov-2016$1250

Integrase Inhibitors -Pipeline Insights, 2016

By Delve Insight
"...... linical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA des......"
01-Nov-2016$1250

Epzicom -Drug Insights, 2016

By Delve Insight
"...... des the Epzicom sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Epzicom, patents information and exclusivity data, route of synthesis, competitive lands......"
01-Nov-2016$1000

Eviplera -Drug Insights, 2016

By Delve Insight
"...... ovides the Eviplera sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Eviplera, patents information and exclusivity data, route of synthesis, competitive ......"
01-Nov-2016$1000

Avail upto 50% Discount on below Publisher Reports.